CD271 Serves as a Marker for Tumor-Initiating Cells in Laryngocarcinoma
CD271 serves as a marker for TICs in Hep-2 cells, presenting a novel target for further investigation.
Authors
- Bohao Zhang (ORCID: https://orcid.org/0000-0002-6524-4028)
- Chenzhi Xu
- Fang Geng (ORCID: https://orcid.org/0000-0003-4269-5421)
- Yupeng Shen (ORCID: https://orcid.org/0000-0002-9753-9269)
- Ruifeng Zhang (ORCID: https://orcid.org/0000-0002-3514-0455)
- Xin Liu (ORCID: https://orcid.org/0000-0003-3256-2940)
- Dan Li (ORCID: https://orcid.org/0000-0002-5450-9975)
- Xiaoming Li (ORCID: https://orcid.org/0000-0003-1795-0371)
- Jihua Zhang (ORCID: https://orcid.org/0000-0003-3136-1194)
Institutions
- Hebei Medical University (CN)
- Eye & ENT Hospital of Fudan University (CN)
- Bethune International Peace Hospital (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Discovery Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.24976/discov.med.202537194.46
- Citations
- 2
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 2.09